Keyphrases
Adjuvanted
100%
Chikungunya Virus (CHIKV)
100%
Footpad
100%
Neutralizing Antibodies
100%
Adenovirus Type 5
100%
Virus Vaccine
50%
Virus
16%
Serum Antibody
16%
Antibody Response
16%
Vaccine Development
16%
Virus Strains
16%
Vaccine Strategy
16%
High Risk
16%
Pathological Changes
16%
Structural Proteins
16%
Adenovirus Vaccine
16%
Protective Efficacy
16%
C57BL
16%
Vaccine Vector
16%
Clinical Development
16%
Countries Worldwide
16%
Mosquito-borne Diseases
16%
Clinical Model
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neutralizing Antibody
100%
Chikungunya Virus
100%
Human Adenovirus 5
100%
Virus Vaccine
50%
Disease
33%
Vaccine Development
16%
Structural Protein
16%
Virus Strain
16%
C57BL 6 Mouse
16%
Adenovirus Vaccine
16%
Immunology and Microbiology
Neutralizing Antibody
100%
Chikungunya Virus
100%
Human Adenovirus 5
100%
Virus Vaccine
50%
Antibody Response
16%
Antibody Blood Level
16%
Virus Strain
16%
C57BL 6 Mouse
16%
Adenovirus Vaccine
16%